These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 6391926

  • 21. Sleep and hypnotics.
    Lader M.
    Scott Med J; 1979 Jan; 24(1):59-63. PubMed ID: 493933
    [Abstract] [Full Text] [Related]

  • 22. Insomnia.
    Holzinger E.
    IDrugs; 2005 May; 8(5):410-5. PubMed ID: 15883924
    [Abstract] [Full Text] [Related]

  • 23. [Sleep disorders. Which therapy is recommended when?].
    Schneider-Helmert D.
    Med Monatsschr Pharm; 1988 Aug; 11(8):262-9. PubMed ID: 3063928
    [No Abstract] [Full Text] [Related]

  • 24. [Nitrazepam (Mogadon); report of a study of the therapeutic value in the treatment of insomnia].
    Zelvelder WG.
    Ned Tijdschr Geneeskd; 1966 Oct 29; 110(44):1959-63. PubMed ID: 5341767
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL, McAllister PJ, Bilchik TR.
    Cranio; 2015 Apr 29; 33(2):115-21. PubMed ID: 25323219
    [Abstract] [Full Text] [Related]

  • 26. [Controlled clinical study of a sleep-inducing drug, ethodroxizine].
    Fedeli S.
    Brux Med; 1968 Aug 29; 48(8):517-8. PubMed ID: 4924597
    [No Abstract] [Full Text] [Related]

  • 27. Understanding and treating insomnia.
    Bootzin RR, Epstein DR.
    Annu Rev Clin Psychol; 2011 Aug 29; 7():435-58. PubMed ID: 17716026
    [Abstract] [Full Text] [Related]

  • 28. Diazepam in the treatment of insomnia in psychiatric patients.
    Ananth JV, Bronheim LA, Klingner A, Ban TA.
    Curr Ther Res Clin Exp; 1973 Apr 29; 15(4):217-22. PubMed ID: 4633283
    [No Abstract] [Full Text] [Related]

  • 29. Insomnia and short-acting benzodiazepine hypnotics.
    Lader MH.
    J Clin Psychiatry; 1983 Feb 29; 44(2):47-53. PubMed ID: 6826530
    [Abstract] [Full Text] [Related]

  • 30. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.
    Bes F, Hofman W, Schuur J, Van Boxtel C.
    Neuropsychobiology; 1992 Feb 29; 26(4):193-7. PubMed ID: 1299794
    [Abstract] [Full Text] [Related]

  • 31. Symptoms that depress the doctor. Insomnia.
    Oswald I.
    Br J Hosp Med; 1984 Mar 29; 31(3):219-21, 224. PubMed ID: 6143580
    [No Abstract] [Full Text] [Related]

  • 32. A double-blind clinical trial of a new sleep-inducing combination of methaqualone and etodroxizine compared with nitrazepam and placebo.
    Kullander NE.
    Arzneimittelforschung; 1969 Sep 29; 19(9):1530-2. PubMed ID: 4899293
    [No Abstract] [Full Text] [Related]

  • 33. Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors.
    Dick P, Grandjean ME, Tissot R.
    Neuropsychobiology; 1983 Sep 29; 10(4):205-8. PubMed ID: 6328354
    [Abstract] [Full Text] [Related]

  • 34. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Sep 29; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

  • 35. [Opiate receptors and sleep. III. Effects of microinjections of DSIP (delta-sleep peptide) in the median thalamus, Periaqueductal gray matter and nucleus of the tractus solitarius of the rabbit (author's transl)].
    Tissot R.
    Neuropsychobiology; 1981 Sep 29; 7(6):321-5. PubMed ID: 6273764
    [Abstract] [Full Text] [Related]

  • 36. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.
    Friedman TC, García-Borreguero D, Hardwick D, Akuete CN, Doppman JL, Dorn LD, Barker CN, Yanovski JA, Chrousos GP.
    Neuroendocrinology; 1994 Dec 29; 60(6):626-34. PubMed ID: 7700506
    [Abstract] [Full Text] [Related]

  • 37. [Clinical pharmacology of hypnotics. Methodologic problems].
    Jequier JC, Gagnon MA, Pinard G, Nabet M, Tetreault L.
    Therapie; 1976 Dec 29; 31(1):43-58. PubMed ID: 8855
    [No Abstract] [Full Text] [Related]

  • 38. Zolpidem for insomnia related to PTSD.
    Dieperink ME, Drogemuller L.
    Psychiatr Serv; 1999 Mar 29; 50(3):421. PubMed ID: 10096658
    [No Abstract] [Full Text] [Related]

  • 39. A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.
    Krystal AD, Huang H, Zummo J, Grinnell T, Marshall RD.
    Sleep Med; 2012 Jun 29; 13(6):691-6. PubMed ID: 22465450
    [Abstract] [Full Text] [Related]

  • 40. Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP).
    Schoenenberger GA.
    Eur Neurol; 1984 Jun 29; 23(5):321-45. PubMed ID: 6548966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.